Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Merlin/NF2 Loss in Meningioma Biology
Sung‐Ho Lee, Patrick J. Karas, Caroline Hadley, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1633-1633
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance
Frank Szulzewsky, Eric C. Holland, Valeri Vasioukhin
Developmental Biology (2021) Vol. 475, pp. 205-221
Open Access | Times Cited: 113
An Overview of Managements in Meningiomas
Lianhua Zhao, Wei Zhao, Yanwei Hou, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 75
Molecular alterations in meningioma: prognostic and therapeutic perspectives
Cristina Birzu, Matthieu Peyre, Felix Sahm
Current Opinion in Oncology (2020) Vol. 32, Iss. 6, pp. 613-622
Closed Access | Times Cited: 72
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome
H. Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.
Cell Genomics (2024) Vol. 4, Iss. 6, pp. 100566-100566
Open Access | Times Cited: 8
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Duo Xu, Shiyuan Yin, Yongqian Shu
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 6
From kidney injury to kidney cancer
Anna Julie Peired, Elena Lazzeri, Francesco Guzzi, et al.
Kidney International (2021) Vol. 100, Iss. 1, pp. 55-66
Open Access | Times Cited: 39
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma
Haitang Yang, Sean R. R. Hall, Beibei Sun, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1561-1561
Open Access | Times Cited: 34
Treatment of WHO Grade 2 Meningiomas With Stereotactic Radiosurgery: Identification of an Optimal Group for SRS Using RPA
Roman O. Kowalchuk, Matthew J. Shepard, Kimball Sheehan, et al.
International Journal of Radiation Oncology*Biology*Physics (2021) Vol. 110, Iss. 3, pp. 804-814
Closed Access | Times Cited: 33
Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia
Huabo Wang, Jie Lu, Frances Alencastro, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 13, Iss. 6, pp. 1785-1804
Open Access | Times Cited: 20
Primary Benign Tumors of the Spinal Canal
José Alberto Carlos-Escalante, Ángel-Antonio Paz-López, Bernardo Cacho‐Díaz, et al.
World Neurosurgery (2022) Vol. 164, pp. 178-198
Closed Access | Times Cited: 20
Lead exposure promotes <i>NF2-wildtype</i> meningioma cell proliferation through the Merlin-Hippo signaling pathway
Nenghua Zhang, Xuehuai Shen, Yunnong Yu, et al.
Environmental Health and Preventive Medicine (2025) Vol. 30, pp. 8-8
Open Access
Acylcarnitine Profiling in Meningiomas with Different NF2 Mutation Statuses
Joanna Bogusiewicz, Jacek Furtak, Marcin Birski, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1570-1570
Open Access
Lipidomic profile of meningiomas harboring different NF2 mutation status
Joanna Bogusiewicz, I. Stanimirova, Magdalena Gaca-Tabaszewska, et al.
Research Square (Research Square) (2025)
Closed Access
Recent advances in the molecular prognostication of meningiomas
Elaina J. Wang, Alexander F. Haddad, Jacob S. Young, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 9
Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma
Huiyuan Zhang, Lin Qi, Yuchen Du, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1478-1478
Open Access | Times Cited: 27
Comparative clinical and genomic analysis of neurofibromatosis type 2-associated cranial and spinal meningiomas
Alexander Pemov, Ramita Dewan, Nancy F. Hansen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity
Artem Gridnev, Subhajit Maity, Jyoti R. Misra
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
The biological and diagnostic roles of MicroRNAs in meningiomas
Lei Wang, Shengpan Chen, Yan Liu, et al.
Reviews in the Neurosciences (2020) Vol. 31, Iss. 7, pp. 771-778
Closed Access | Times Cited: 20
Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapies
Ahmad Nazem, Jacob Ruzevick, Manuel Ferreira
Oncotarget (2020) Vol. 11, Iss. 49, pp. 4544-4553
Open Access | Times Cited: 19
Development of Novel Bioluminescent Biosensors Monitoring the Conformation and Activity of the Merlin Tumour Suppressor
Alexander Pipchuk, Tynan Kelly, Madeleine Carew, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1527-1527
Open Access | Times Cited: 2
The role of systemic inflammatory cells in meningiomas
Jeppe Haslund-Vinding, Jens Möller, Morten Ziebell, et al.
Neurosurgical Review (2021) Vol. 45, Iss. 2, pp. 1205-1215
Closed Access | Times Cited: 13
A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors
Ankit Halder, Deeptarup Biswas, Aparna Chauhan, et al.
Clinical Proteomics (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
Reem Halabi, Fatima Dakroub, Mohammad Z. Haider, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5339-5339
Open Access | Times Cited: 5
Meningiomas: A review of general, histopathological, clinical and molecular characteristics
Débora Salles, Samara Ferreira Santino, Andréa Cristina de Moraes Malinverni, et al.
Pathology - Research and Practice (2021) Vol. 223, pp. 153476-153476
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top